[Human kallikreins as tumor markers. Validation of potential marker of prostate cancer in serum and tissue].
Rabien
A
A
Klinik für Urologie, Charité--Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin. anja.rabien@charite.de
Kristiansen
G
G
Diamandis
E P
EP
Jung
K
K
Stephan
C
C
D000230:Adenocarcinoma / Q000097:blood* / Q000473:pathology / Q000601:surgery; D014408:Biomarkers, Tumor / Q000097:blood*; D018572:Disease-Free Survival; D006801:Humans; D007610:Kallikreins / Q000097:blood*; D053208:Kaplan-Meier Estimate; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011467:Prostate / Q000473:pathology*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000473:pathology / Q000601:surgery; D020840:Tissue Kallikreins / Q000097:blood*
D014408:Biomarkers, Tumor; C425336:KLK14 protein, human; C501608:KLK15 protein, human; D007610:Kallikreins; D020840:Tissue Kallikreins